Collectively, such a conclusion could be drawn that miR-887-3p incorporated in MDA-MB-231-derived EVs promoted BC cell drug resistance by targeting BTBD7 and activating the Notch1/Hes1 signaling pathway (Figure 8). This evidence concerns the gene HES1 and breast cancer.